Literature DB >> 9386968

A laboratory model of cocaine withdrawal in humans: intravenous cocaine.

R W Foltin1, M W Fischman.   

Abstract

Seven adult intravenous (IV) cocaine users completed a protocol investigating changes in behavior after the self-administration of cocaine. During sessions, the participants could self-administer up to 6 doses of IV cocaine (32 mg/70 kg) twice each day. Both 2- and 3-day binge conditions were tested. At 39 hr after the 3-day but not the 2-day binge of cocaine use, total Beck Depression Inventory scores were increased and participants reported increased ratings of Irritable and decreased ratings of I Want Cocaine. Exposure to stimulus cues associated with IV cocaine increased ratings of I Want Cocaine during periods of abstinence after both 2- and 3-day binges and increased ratings of Depressed only after the 3-day binge of cocaine use. The cessation of binge cocaine use produced modest changes in mood and cocaine craving that were related to the length of the binge and varied as a function of time since last cocaine use. Responsiveness to cocaine cues also varied as a function of the length of the previous cocaine binge.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9386968     DOI: 10.1037//1064-1297.5.4.404

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  13 in total

1.  Daily life hour by hour, with and without cocaine: an ecological momentary assessment study.

Authors:  David H Epstein; Kenzie L Preston
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

2.  EVALUATION OF DRUG ABUSE TREATMENT MEDICATIONS: CONCORDANCE BETWEEN CLINICAL AND PRECLINICAL STUDIES.

Authors:  N K Mello
Journal:  NIDA Res Monogr       Date:  2005-05

3.  Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance.

Authors:  Suzanne K Vosburg; Margaret Haney; Eric Rubin; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2010-03-25       Impact factor: 4.492

Review 4.  Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

5.  A paradigm to investigate the self-regulation of cocaine administration in humans.

Authors:  Atapol Sughondhabirom; Diwakar Jain; Ralitza Gueorguieva; Vladimir Coric; Robert Berman; Wendy J Lynch; David Self; Peter Jatlow; Robert T Malison
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

6.  The effects of aerobic exercise on cocaine self-administration in male and female rats.

Authors:  Mark A Smith; Katherine L Walker; Kathryn T Cole; Kimberly C Lang
Journal:  Psychopharmacology (Berl)       Date:  2011-05-13       Impact factor: 4.530

7.  Regulation of cocaine self-administration in humans: lack of evidence for loading and maintenance phases.

Authors:  Gustavo A Angarita; Brian Pittman; Ralitza Gueorguieva; Rasmon Kalayasiri; Wendy J Lynch; Atapol Sughondhabirom; Peter T Morgan; Robert T Malison
Journal:  Pharmacol Biochem Behav       Date:  2009-12-21       Impact factor: 3.533

Review 8.  Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.

Authors:  Margaret Haney
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

9.  The effects of social contact on cocaine intake under extended-access conditions in male rats.

Authors:  Andrea M Robinson; Ryan T Lacy; Justin C Strickland; Charlotte P Magee; Mark A Smith
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

10.  Evidence for habitual and goal-directed behavior following devaluation of cocaine: a multifaceted interpretation of relapse.

Authors:  David H Root; Anthony T Fabbricatore; David J Barker; Sisi Ma; Anthony P Pawlak; Mark O West
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.